These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 37018139)

  • 1. COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project.
    Rutter M; Lanyon PC; Grainge MJ; Hubbard R; Bythell M; Stilwell P; Aston J; McPhail S; Stevens S; Pearce FA
    Rheumatology (Oxford); 2023 Dec; 62(12):3828-3837. PubMed ID: 37018139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project.
    Rutter M; Lanyon PC; Grainge MJ; Hubbard R; Peach E; Bythell M; Stilwell P; Aston J; Stevens S; Pearce FA
    Rheumatology (Oxford); 2022 Aug; 61(8):3161-3171. PubMed ID: 34698821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of death among people with rare autoimmune diseases compared with the general population in England during the 2020 COVID-19 pandemic.
    Peach E; Rutter M; Lanyon P; Grainge MJ; Hubbard R; Aston J; Bythell M; Stevens S; Pearce F
    Rheumatology (Oxford); 2021 Apr; 60(4):1902-1909. PubMed ID: 33271595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk prediction of covid-19 related death or hospital admission in adults testing positive for SARS-CoV-2 infection during the omicron wave in England (QCOVID4): cohort study.
    Hippisley-Cox J; Khunti K; Sheikh A; Nguyen-Van-Tam JS; Coupland CAC
    BMJ; 2023 Jun; 381():e072976. PubMed ID: 37343968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform.
    Williamson EJ; McDonald HI; Bhaskaran K; Walker AJ; Bacon S; Davy S; Schultze A; Tomlinson L; Bates C; Ramsay M; Curtis HJ; Forbes H; Wing K; Minassian C; Tazare J; Morton CE; Nightingale E; Mehrkar A; Evans D; Inglesby P; MacKenna B; Cockburn J; Rentsch CT; Mathur R; Wong AYS; Eggo RM; Hulme W; Croker R; Parry J; Hester F; Harper S; Douglas IJ; Evans SJW; Smeeth L; Goldacre B; Kuper H
    BMJ; 2021 Jul; 374():n1592. PubMed ID: 34261639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study.
    Shin YH; Shin JI; Moon SY; Jin HY; Kim SY; Yang JM; Cho SH; Kim S; Lee M; Park Y; Kim MS; Won HH; Hong SH; Kronbichler A; Koyanagi A; Jacob L; Smith L; Lee KH; Suh DI; Lee SW; Yon DK
    Lancet Rheumatol; 2021 Oct; 3(10):e698-e706. PubMed ID: 34179832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study.
    Clift AK; Coupland CAC; Keogh RH; Diaz-Ordaz K; Williamson E; Harrison EM; Hayward A; Hemingway H; Horby P; Mehta N; Benger J; Khunti K; Spiegelhalter D; Sheikh A; Valabhji J; Lyons RA; Robson J; Semple MG; Kee F; Johnson P; Jebb S; Williams T; Hippisley-Cox J
    BMJ; 2020 Oct; 371():m3731. PubMed ID: 33082154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Look after the COVID-19 pandemic: Mortality rates among patients with rheumatic diseases.
    Çimen Güneş E; Çolak S; Şenlik ZB; Tekgöz E; Altunay K; Özdemirkan T; Aytaç BC; Şimşek AÇ; Çınar M; Yılmaz S
    Int J Rheum Dis; 2024 Mar; 27(3):e15129. PubMed ID: 38514928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immunity in patients with rare autoimmune rheumatic diseases following SARS-CoV-2 vaccination.
    Gumber L; Gomez N; Hopkins G; Tucis D; Bartlett L; Ayling K; Vedhara K; Steers G; Chakravorty M; Rutter M; Jackson H; Tighe P; Ferraro A; Power S; Pradère MJ; Onion D; Lanyon PC; Pearce FA; Fairclough L
    Rheumatology (Oxford); 2023 Jun; 62(6):2294-2303. PubMed ID: 36250898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study.
    Barron E; Bakhai C; Kar P; Weaver A; Bradley D; Ismail H; Knighton P; Holman N; Khunti K; Sattar N; Wareham NJ; Young B; Valabhji J
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):813-822. PubMed ID: 32798472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records.
    Thygesen JH; Tomlinson C; Hollings S; Mizani MA; Handy A; Akbari A; Banerjee A; Cooper J; Lai AG; Li K; Mateen BA; Sattar N; Sofat R; Torralbo A; Wu H; Wood A; Sterne JAC; Pagel C; Whiteley WN; Sudlow C; Hemingway H; Denaxas S;
    Lancet Digit Health; 2022 Jul; 4(7):e542-e557. PubMed ID: 35690576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients.
    FAI2R /SFR/SNFMI/SOFREMIP/CRI/IMIDIATE consortium and contributors
    Ann Rheum Dis; 2021 Apr; 80(4):527-538. PubMed ID: 33268442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.
    Holman N; Knighton P; Kar P; O'Keefe J; Curley M; Weaver A; Barron E; Bakhai C; Khunti K; Wareham NJ; Sattar N; Young B; Valabhji J
    Lancet Diabetes Endocrinol; 2020 Oct; 8(10):823-833. PubMed ID: 32798471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess mortality in England and Wales during the first wave of the COVID-19 pandemic.
    Kontopantelis E; Mamas MA; Deanfield J; Asaria M; Doran T
    J Epidemiol Community Health; 2021 Mar; 75(3):213-223. PubMed ID: 33060194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study.
    Gao M; Piernas C; Astbury NM; Hippisley-Cox J; O'Rahilly S; Aveyard P; Jebb SA
    Lancet Diabetes Endocrinol; 2021 Jun; 9(6):350-359. PubMed ID: 33932335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level and hospital-level variation and related time trends in COVID-19 case fatality rates during the first pandemic wave in England: multilevel modelling analysis of routine data.
    Bottle A; Faitna P; Aylin PP
    BMJ Qual Saf; 2022 Mar; 31(3):211-220. PubMed ID: 34234008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study.
    Bosworth ML; Ayoubkhani D; Nafilyan V; Foubert J; Glickman M; Davey C; Kuper H
    Lancet Public Health; 2021 Nov; 6(11):e817-e825. PubMed ID: 34626547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding covid-19 outcomes among people with intellectual disabilities in England.
    Sosenko F; Mackay D; Pell JP; Hatton C; Jani BD; Cairns D; Ward L; Henderson A; Fleming M; Nijhof D; Melville C;
    BMC Public Health; 2023 Oct; 23(1):2099. PubMed ID: 37880687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases.
    Bakasis AD; Mavragani CP; Voulgari PV; Gerolymatou N; Argyropoulou OD; Vlachoyiannopoulos PG; Skopouli FN; Tzioufas AG; Moutsopoulos HM
    J Autoimmun; 2022 Jul; 131():102846. PubMed ID: 35717727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.